Literature DB >> 19869645

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS.

O T Avery1, W F Goebel.   

Abstract

1. When two chemically different carbohydrate derivatives are bound to the same protein, the newly formed antigens exhibit distinct immunological specificity. 2. When the same carbohydrate radical is conjugated with two chemically different and serologically distinct proteins both of the sugar-proteins thus formed acquire a common serological specificity. 3. The newly acquired specificity of the artificially prepared sugar-proteins is determined by the chemical constitution of the carbohydrate radical attached to the protein molecules. Simple differences in the molecular configuration of the two isomers,-glucose and galactose-suffice to orientate protein specificity when the corresponding glucosides of the two sugars are coupled to the same protein. 4. The unconjugated glucosides, although themselves not precipitable in immune serum, inhibit the reaction between the homologous sugar-protein and its specific antibody. The inhibition test is specific. 5. The sugar derivatives unattached to protein exhibit the properties of carbohydrate haptens; they are non-antigenic but specifically reactive, as shown by inhibition tests, with antibodies induced by proteins containing the homologous diazotized glucoside. 6. The specificity of artificially prepared sugar-proteins is discussed with reference to the chemo-immunological nature of the bacterial antigens containing complex sugars.

Entities:  

Year:  1929        PMID: 19869645      PMCID: PMC2131643          DOI: 10.1084/jem.50.4.533

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  1 in total

1.  CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : I. THE SYNTHESIS OFp-AMINOPHENOL beta-GLUCOSIDE, p-AMINOPHENOL beta-GALACTOSIDE, AND THEIR COUPLING WITH SERUM GLOBULIN.

Authors:  W F Goebel; O T Avery
Journal:  J Exp Med       Date:  1929-09-30       Impact factor: 14.307

  1 in total
  82 in total

1.  B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.

Authors:  T L McCool; C V Harding; N S Greenspan; J R Schreiber
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 2.  Conjugate vaccines.

Authors:  D Goldblatt
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

3.  A sweet T cell response.

Authors:  Rino Rappuoli; Ennio De Gregorio
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

Review 4.  Serotype-independent pneumococcal experimental vaccines that induce cellular as well as humoral immunity.

Authors:  Richard Malley; Porter W Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-02       Impact factor: 11.205

5.  Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United Kingdom.

Authors:  G Tudor-Williams; J Frankland; D Isaacs; R T Mayon-White; J A MacFarlane; D G Rees; E R Moxon
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

Review 6.  From glycophenotyping by (plant) lectin histochemistry to defining functionality of glycans by pairing with endogenous lectins.

Authors:  Herbert Kaltner; Gabriel García Caballero; Anna-Kristin Ludwig; Joachim C Manning; Hans-Joachim Gabius
Journal:  Histochem Cell Biol       Date:  2018-05-05       Impact factor: 4.304

Review 7.  Pneumonia research to reduce childhood mortality in the developing world.

Authors:  J Anthony G Scott; W Abdullah Brooks; J S Malik Peiris; Douglas Holtzman; E Kim Mulholland
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

8.  Influence of prevaccination immunity on the human B-lymphocyte response to a Haemophilus influenzae type b conjugate vaccine.

Authors:  T Barington; K Kristensen; J Henrichsen; C Heilmann
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Preliminary Report upon Pollen Carbohydrate As a Therapeutic Agent for Pollen Asthma.

Authors:  A H Caulfeild
Journal:  Trans Am Clin Climatol Assoc       Date:  1934

10.  On the mechanisms of conjugate vaccines.

Authors:  Rino Rappuoli; Ennio De Gregorio; Paolo Costantino
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.